Background Recent evidence from cross‐sectional and longitudinal studies supports the
hypothesis that sarcopenia is associated with worsening cognitive function. However …

Background Much interest has been focused on interventions for treating sarcopenia;
however, the effects have gained little evidence. Objective To analyze the effectiveness of …

Background Sarcopenia shares risk factors with various other age-related diseases. This
meta-analysis aimed to determine the prevalence of sarcopenia as a comorbid disease …

Introduction Sarcopenia is an aging-related health problem in the geriatric population.
Sarcopenia reduces muscle mass, muscle strength, and physical performance. Although …

Objective The purpose of this study was to perform a systematic review to assess the short-,
middle-and long-term consequences of sarcopenia. Methods Prospective studies assessing …

Sarcopenia refers to age‐associated decrease in muscle mass and function. The condition
was originally described in the elderly, but emerging evidence suggests that it is also a …

Sarcopenia, with risk factors such as poor nutrition and physical inactivity, is becoming
prevalent among the older population. The aims of this study were (i) to systematically …

Objective this study aimed to investigate how sarcopenia has been defined and measured in
the literature reporting its prevalence, and how different definitions and measurement tools …

Background Metabolic risk factors can impact sarcopenia, but the direct relationship of
metabolic risk factors with sarcopenia has not been examined. Our purpose was to …

Background Depression may be the most common cause of emotional distress later in life
and can significantly reduce the quality of life in elderly individuals. Sarcopenia is a …